EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cytokine epigenetics network for gastric cancer progression and chemoresistance

Ganji Purnachandra Nagaraju, Seema Kumari, Mundla Srilatha, Irina Nakashidze, Bassel F El-Rayes

Pharmacological Research · 2026

DOI: 10.1016/j.phrs.2026.108136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026. Verfasst von Ganji Purnachandra Nagaraju und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama, Birmingham, AL 35233, US…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Epigenesis, Genetic, Drug Resistance, Neoplasm, Cytokines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Alabama at Birmingham, The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is a leading cause of cancer mortality due to late diagnosis, metastasis, and therapy resistance. Epigenetic modifications rewire the cytokine network, facilitating the development, progression, and chemoresistance of GC. Cytokines regulate immune and inflammatory responses through various pathways, including the IL-6/JAK/STAT pathway, MAP Kinase, NF-κB signaling, IL-8/NF-κB, and the TGF-β axis, which sustain persistent inflammation and oncogenic signaling. The expression of these regulatory molecules is tightly controlled by epigenetic changes, including DNA methylation, histone modification, chromatin remodeling, and miRNA sponging. In addition, this is influenced by long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), which impact the tumor microenvironment and tumor survival. H. pylori and EBV further remodel cytokine epigenetic networks, promoting tumor progression. LncRNA and circRNAs can play dual roles, acting as both oncogenic and tumor-suppressive agents, where oncogenic ncRNAs, via drug efflux, apoptosis inhibition, autophagy, PD-L1 stabilization, and CSC maintenance, whereas tumor-suppressive ncRNAs restore chemosensitivity and antitumor immunity by reactivating PTEN, MHC-I, and apoptosis, proving to be promising biomarkers and therapeutic targets. Various clinical trials are also discussed in this review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsEpigenesis, GeneticDrug Resistance, NeoplasmCytokinesHumansAnimalsDisease ProgressionAntineoplastic AgentsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ChemoresistanceCytokinesEpigenetic regulationGastric cancerTargeted therapies

Substanzen

CytokinesAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Hematology and Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama, Birmingham, AL 35233, USA.
  • Department of Biotechnology, Dr. B. R. Ambedkar University, Srikakulam, Andhra Pradesh 532001, India.
  • Department of Biotechnology, Sri Venkateswara University, Tirupati, Andhra Pradesh 517502, India.
  • Faculty of Natural Sciences and Health Care, Batumi Shota Rustaveli State University, Batumi, Georgia.
  • Division of Hematology and Oncology, O'Neal Comprehensive Cancer Center, Heersink School of Medicine, University of Alabama, Birmingham, AL 35233, USA; Division of Medical Oncology, Moores Cancer Center, UC San Diego, L…

Förderung

  • University of Alabama at Birmingham
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center

Zitieren

APA

Nagaraju, G. P., Kumari, S., Srilatha, M., Nakashidze, I., & El-Rayes, B. F. (2026). Cytokine epigenetics network for gastric cancer progression and chemoresistance. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.108136

Vancouver

Nagaraju GP, Kumari S, Srilatha M, Nakashidze I, El-Rayes BF. Cytokine epigenetics network for gastric cancer progression and chemoresistance. Pharmacological Research. 2026. doi:10.1016/j.phrs.2026.108136

BibTeX
@article{Nagaraju2026,
  author = {Nagaraju, Ganji Purnachandra and Kumari, Seema and Srilatha, Mundla and Nakashidze, Irina and El-Rayes, Bassel F},
  title = {Cytokine epigenetics network for gastric cancer progression and chemoresistance},
  journal = {Pharmacological Research},
  year = {2026},
  doi = {10.1016/j.phrs.2026.108136}
}
Kostenlos starten →